Targeting Nicotinic Receptors for Parkinson's Disease Therapy

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 6, 2011-09 ,pp. : 651-658

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Nicotinic Acetylcholine Receptors (nAChRs) in Astrocytes as a Potential Therapeutic Target in Parkinson’s Disease

By  

Current Pharmaceutical Design, Vol. 22, Iss. 10, 2016-03 ,pp. : 1305-1311

Bentham Science Publishers

Access to resources Recommend Favorite

α7 Nicotinic Acetylcholine Receptor Mediated Neuroprotection in Parkinson’s Disease

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 623-630

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate Receptors and Parkinson’s Disease: Opportunities for Intervention

By Marino M.J.   Valenti O.   Conn P.J.  

Drugs & Aging, Vol. 20, Iss. 5, 2003-01 ,pp. : 377-397

Adis International

Access to resources Recommend Favorite

Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease

By Maelicke A.   Albuquerque E.X.  

European Journal of Pharmacology, Vol. 393, Iss. 1, 2000-03 ,pp. : 165-170

Elsevier

Access to resources Recommend Favorite